万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://febs.onlinelibrary.wiley.com/journal/22115463
3、投稿网址：
https://mc.manuscriptcentral.com/febsopen
4、官网邮箱：openbio@febs.org（编辑部）
delarosa@febs.org（主编）
5、官网电话：+44 (0)1223 369020（编辑部）
6、期刊刊期：月刊，一年出版十二期。
2021年4月16日星期五
投稿须知【官网信息】
Author Guidelines
Information about FEBS Open Bio
Aims and Scope
FEBS Open Bio is an online-only open access journal for the rapid publication of research articles in molecular and cellular life sciences in both health and disease. The journal's peer review process focuses on the technical soundness of papers, leaving the assessment of their impact and importance to the scientific community.
FEBS Open Bio publishes experimental findings, critical analysis, methodological and technical innovations, and hypotheses. Novel or innovative work is encouraged, but papers describing sound science of a confirmatory nature in developing fields or extending knowledge of an important topic from one organism to another will also be considered.
Articles originally submitted to other FEBS Press publications (FEBS Letters , The FEBS Journal and Molecular Oncology) can be transferred for consideration by FEBS Open Bio with their original reviewer reports, without the need to resubmit or reformat the manuscript.
Why publish in FEBS Open Bio?
FEBS Open Bio offers:
Easy online manuscript submission and tracking system
Transfer service for articles from other FEBS journals, conserving peer reviews
Fast publication
Accepted articles published online within 7 days
Author-corrected final version available within 20 days
All articles are deposited in PubMed Central and indexed in PubMed
Editorial board
Information about the journal’s editorial board is available here:
https://febs.onlinelibrary.wiley.com/hub/journal/22115463/editorial-board/editorial-board
Contact us
For inquiries relating to the submission or reviewing process, please contact the Editorial Office at openbio@febs.org. Contact details for questions arising after acceptance of an article, especially those relating to proofs, will be provided by our publishers, Wiley.
Reviewing process
FEBS Open Bio is committed to maintaining high standards of peer review. All submissions are handled by an active scientist on our editorial board, and they send all submissions that meet the required criteria (robust methodology, sound ethical standards, and careful interpretation of data) for peer review by experts in the field. Our peer reviewers include members of our Editorial Advisory Board, our Volunteer Reviewers, or external experts, depending on the expertise required. We endeavour to review all submissions within a reasonable time frame.
Open access license and article processing charge
Open access license
This journal is Open Access; all articles will be immediately and permanently free for everyone to read and download.
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.
FEBS Open Bio offers corresponding authors the following license agreement:
Creative Commons Attribution License CC BY
To preview the terms and conditions of this open access agreement, please visit http://creativecommons.org/licenses/by/4.0/.
Article processing charge
FEBS Open Bio is an Open Access journal with no subscribers. A fee is payable by the author or research funder to cover the costs associated with publication. This ensures each article will be immediately and permanently free for anyone to access. The Open Access publication fee for this journal is US$1850 / £1450 / €1650. Authors transferring their papers from either The FEBS Journal, FEBS Letters or Molecular Oncology are entitled to a 10% discount. Authors will be asked to pay the article publication charge on acceptance of their article. For articles for the Education Section, the publication costs will be covered by FEBS.
Your institute or funder may have an agreement with Wiley to pay all or some of the article publication charge on your behalf. You can check here. Waivers and discounts are available to authors from countries eligible for the Research4Life programs. You can check the lists of countries here.
Questions related to Open Access publication fees and waivers should be sent to cs-openaccess@wiley.com
Education Section
The Education section of FEBS Open Bio is devoted to research articles in molecular and cellular life sciences education, with the aim of disseminating advice on education techniques and resources. It is strongly encouraged that the articles include a hypothesis, methods, and validation of results. Articles dealing with best practice, innovative methods, teaching bioinformatics, and use of technology in education are welcome, as are those more specifically aimed at internationalization, training or career planning. There is no cost to authors for this section as the publication costs will be covered by FEBS.
Editorial Policies
Ethical standards
All submissions to FEBS Open Bio should conform to standard ethical guidelines, details of which can be found on the website of the Committee on Publication Ethics (COPE). See also Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals http://www.icmje.org
FEBS Open Bio employs a plagiarism detection system (iThenticate). By submitting your manuscript to this publication you accept that your manuscript may be screened for plagiarism against previously published works.
Conflicts of interest
All authors are requested to disclose any actual or potential conflicts of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work.
Funding sources
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in: study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.
Submission declaration
Submission of an article implies that the work described:
Has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint)
That it is not under consideration for publication elsewhere;
That its publication is approved by all authors and, tacitly or explicitly, by the responsible authorities where the work was carried out.
In the event that duplicate submission or prior publication are suspected, the journal reserves the right to share our work with other journals as part of our investigation.
Authorship
Authors are required to meet the criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICMJE). The specific contributions of each author must be described in an Author Contributions statement.
Requests to add or remove an author, or to rearrange the author names, after acceptance of your paper must be sent to the Editorial Office and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors, including those authors added or omitted, that they agree with the addition, removal or rearrangement. Any requests to add, delete, or rearrange author names after the article is published online will follow the same policies as noted above and result in a corrigendum.
Work involving human or animal subjects or tissues
FEBS Open Bio endorses the updated ARRIVE 2.0 Guidelines for reporting in vivo animal experiments. Authors are expected to, at a minimum, include the Essential 10 set of items that are explained and elaborated with examples here and at the ARRIVE Guidelines website. We encourage authors to also include the Recommended Set of items to support best reporting practice, which promotes reproducibility of animal-based research.
Authors should include in the Materials and Methods (Experimental Procedures) section:
A statement identifying the institutional and/or licensing committee approving the experiments, including any relevant details. Care and use of experimental animals must comply with all relevant local animal welfare laws, guidelines and policies. For research reporting experiments on live vertebrates and/or higher invertebrates, experiments must comply with relevant institutional and national guidelines and regulations.
A full description of the anaesthetic and surgical procedures used, and of peri-operative care.
Evidence that authors took adequate steps to ensure that animals did not suffer unnecessarily at any stage of an experiment, whether acute or chronic.
Research involving human subjects or human tissues should comply with The Code of Ethics of the World Medical Association (Declaration of Helsinki). Please include a statement within the Materials and Methods section, indicating that written informed consent has been obtained from each subject, and that the study methodologies have approval from the appropriate local ethics committee.
Preprints
FEBS Open Bio supports rapid and open scientific communication. Authors are free to upload their work to their personal website, their company’s/institution’s repository or archive, or a not-for-profit subject-based preprint server or repository ahead of or concurrently with submission to the journal. Posting a manuscript to a recognised preprint server does not constitute prior publication.
Data accessibility
FEBS Open Bio expects that data supporting the results in the paper will be archived in an appropriate public repository, where available. Authors of Research Articles, Hypotheses and Methods are required to provide a statement of Data Availability which should briefly describe the availability of the supporting data, whether contained in the manuscript (as Supplementary Information), deposited elsewhere, or any exceptions or limitations to the sharing of data or materials. Large-scale or structured datasets must be deposited in appropriate public databases and a link to the repository and the persistent identifier of the dataset (e.g. DOI or accession number) should be included in the data availability statement. Whenever possible, the scripts and other artefacts used to generate the analyses presented in the paper should also be publicly archived. Authors are not expected to share data that is sensitive in nature or should not be made publicly available due to privacy, security, and/or safety concerns, such as human subject data or the location of endangered species.
See https://febs.onlinelibrary.wiley.com/hub/data-policy for standard templates to follow when compiling your data availability statement (Table 1) and for details of suitable repositories for structured datasets (Table 2).
In addition, throughout the text, accession numbers for data stored in external databases will be hyperlinked to provide access to these data if provided in the following format: Database: XXXX For example, for the entry 1BEN in the Protein Data Bank, use “PDB: 1BEN”.
Types of manuscripts
Research articles
Research articles in all areas of the molecular and cellular life sciences in both health and disease are welcome. Clinical studies should provide insight into the molecular mechanism of the treatment. Innovative work is encouraged, but papers describing sound science of a confirmatory nature in developing fields or extending knowledge of an important topic from one organism to another will also be considered, as will reports of negative results.
Hypothesis
Hypotheses should be topical and of interest to a wide audience and not just specialists. They may present novel ideas or new interpretations of established observations, but should be based on sound data and avoid excessive speculation.
Review
Reviews should be topical and of interest to a wide audience and not just specialists. Reviews are generally invited and unsolicited reviews are rarely considered. Potential authors of review articles should first contact the Editorial Office at openbio@febs.org, providing a short summary and key references for the proposed review.
Method
FEBS Open Bio welcomes articles that describe methodological and technical innovations that are of interest to a broad readership.
Education Article
Education articles should have a clear structure of hypothesis, methods and validation of results. We welcome articles dealing with best practice, innovative methods, teaching bioinformatics, use of technology in education, internationalization and training or career planning. However, this section will not consider practical papers on teaching methods, reports on education experiences or reviews of educational resources.
Preparing your manuscript
Article Preparation Support
Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.
Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.
Format of initial submission
Initial submissions to FEBS Open Bio may be made in any format, including as a single file. All manuscripts must contain the essential elements needed to convey your manuscript, for example Title, Author names and affiliations, Abstract, Keywords, Introduction, Materials and Methods, Results, Conclusions, Figures and Tables with Captions.
Title page
Title. This should state the subject of the manuscript clearly and concisely, with a maximum of 150 characters (including spaces). Titles should be optimized for discovery by search engines, see http://authorservices.wiley.com/bauthor/seo.asp. Avoid abbreviations and formulae where possible. The editors of FEBS Open Bio may edit titles for length and clarity.
Authors’ names and affiliations. Affiliations (where the actual work was done) of all authors should be provided. The corresponding author should also provide a full postal address, telephone number, and an email address. If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name.
Keywords. Please provide a maximum of 6 keywords that reflect the significant factors of the whole investigation. Keywords will be used for indexing and information retrieval. Only include abbreviations firmly established in the field.
Abbreviations. Please provide a list that defines all abbreviations used in the article that are not standard in the field. Ensure consistency of abbreviations throughout the article.
Running heading. Please provide a short title of not more than 50 characters including spaces.
Abstract
A concise (a maximum of 250 words) and factual abstract is required. The abstract should state (1) the purpose of the research, (2) the principal results and (3) major conclusions. Non-standard or uncommon abbreviations should be avoided but, if essential, they must be defined at their first mention within the abstract. Include your keywords to optimize discovery by search engines.
Introduction
State the objectives of the work and provide an adequate background, avoiding a detailed literature survey or a summary of the results.
Methods
Provide sufficient detail to allow the work to be reproduced. Methods already published should be indicated by a reference; only relevant modifications should be described. If experiments involving human or animal subjects or tissues have been carried out, then a statement about ethical approval must be included here; see Editorial policies for further information.
Results
Results should be clear and concise. Follow a logical flow for the experiments, which may not be in the same order as they were performed. Include all relevant data needed to support the conclusions.
Discussion
The Discussion should explore the significance of the results, not repeat them. A combined Results and Discussion section is often appropriate. Avoid extensive citations and discussion of the published literature.
Conclusions
The main text should end with a short statement of the main conclusions of the study. This can be part of the Discussion or have a separate heading.
Data accessibility
Please add a statement, giving accession numbers or DOIs of any data related to this paper that are available in a public database or repository. See Editorial Policies above for further details.
Author contributions
List here the specific contributions of each author (e.g. AA and BB conceived and designed the project, AA, CC and DD acquired the data, AA and CC analysed and interpreted the data, AA and BB wrote the paper).
Acknowledgements
These should be collated in a separate section at the end of the article before the references and not on the title page. List here those individuals who provided help during the research (e.g. provided reagents, corrected language, proof reading, etc.), and identify all funding sources (including grant numbers where appropriate).
Conflicts of interest
All authors are requested to include a statement disclosing any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. If there is no conflict of interest, this should be stated.
References
Where possible, you should cite the primary literature in which observations are first reported rather than reviews. There are no strict requirements on the number of references. Please ensure that every reference cited in the text is also present in the reference list and vice versa. Any references cited in the abstract must be given in full. Unpublished results and personal communications should not be included in the reference list, but may be mentioned in the text. Citation of a reference as 'in press' implies that the item has been accepted for publication. Please provide copies of any crucial ‘in press’ papers for reviewing purposes.
References should be numbered in the order in which they are cited within the text. Please use square brackets around reference numbers (e.g.[1,2].
Please style the reference list as follows:
1 Jensen, MK, Linemose, S, de Masi, F, Reimer, JJ, Nielsen, M, Perera, V, Workman, CT, Turck, F, Grant, MR, Mundy, J, Petersen M & Skriver, K (2013) ATAF1 transcription factor directly regulates abscisic acid biosynthetic gene NCED3 in Arabidopsis thaliana. FEBS Open Bio 3: 321–327
2 Capecchi, MR (2005) Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nat Rev Genet 6: 507–512
3 Brinkman, EK, Chen, T, Amendola, M and van Steensel, B (2014) Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 42: e168, doi: 10.1093/nar/gku936
4 Domagalska MA, Sarnowska E, Nagy F, Davis SJ (2010) Genetic Analyses of Interactions among Gibberellin, Abscisic Acid, and Brassinosteroids in the Control of Flowering Time in Arabidopsis thaliana. PLoS ONE 5: e14012. doi: 10.1371/journal.pone.0014012
5 Sambrook J, Fritsch EF & Maniatis T (1989) Molecular Cloning: A Laboratory Manual. Vol. 3, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
6 Langer T & Neupert W (1994) Chaperoning mitochondrial biogenesis. In The Biology of Heat Shock Proteins and Molecular Chaperones (Morimoto RI, Tissières A & Georgopoulos C, eds), pp. 53–83. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
The use of a tool such as EndNote or Reference Manager is recommended for reference management and formatting.
Tables
Ensure that the data presented in tables does not duplicate results described elsewhere in the article. Tables should be numbered in same order as they appear within the text. Place footnotes to tables below the table body and indicate them with superscript lowercase letters. If using a grid for tables, use only one grid for each table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. Tables can be either included at the end of the main text or supplied as separate files.
Figure legends
Figure legends should appear in the text document following the references, each with a title, and be comprehensible without reference to the text. The figure title must be relevant to the entire figure. Supplementary figure legends should be included in the actual supplementary figure files.
If applicable, error bars should be defined as s.d. or s.e.m. and a precise n value given. Where statistical tests have been used to calculate significance (or lack thereof) the p value should be defined and the name of the statistical test provided in the relevant legend.
Figures
Please make sure that figure files are in an acceptable format (TIFF, EPS, PDF or MS Office files) and that the resolution is at least 300dpi. TIFF files may be saved with using LZW compression. We strongly encourage the use of colour-blind colour palettes in your figures (please refer to this site for examples). Figure manipulation should be reduced to the minimum, in keeping with the following requirements:
In line drawings, lettering and lines must be clear. The axes of each graph should be lettered with the numerical scale, the measured quantity and units.
Photographs must have scale bars where applicable.
Multipart figures should be supplied as one file, in the final layout and with each part labelled.
No specific feature within an image may be selectively enhanced, obscured, moved, removed, or introduced.
The grouping of images from different parts of the same gel, or from different gels, fields, or exposures, must be explicitly labelled both on the figure (i.e., using dividing lines) and in the text of the figure legend. Controls must be on the same blot/gel.
Adjustments of brightness, contrast, or colour balance are acceptable if they are applied to every pixel in the image and as long as they do not obscure, eliminate, or misrepresent any information present in the original, including the background.
In protein or nucleic acid blots or gels the background should be visible but not oversaturated.
In fluorescence images the manipulation of single channels is not allowed.
Molecular weight marker should be indicated on all immunoblots and gels.
All digital images in manuscripts accepted for publication will be scrutinized by our figure checking service for any indication of manipulation that is inconsistent with the above guidelines. Manipulation that violates these guidelines may result in production delays or revocation of acceptance. The editors reserve the right to request original data (including all western blots used for quantification) from authors at any stage in the publication process, including post-publication.
For further information on the preparation of artwork, please click here.
Supplementary information
FEBS Open Bio is published online only with no strict limit for the length of text or number of figures and tables. Thus, all methods, figures and tables should be included within the main text, and not as supplementary files. Supporting Information in the form of background datasets, sound clips and movies can also be published alongside your article. Captions for each supplementary file should be included at the end of the main text file.
Supplementary and supporting Information will not be copyedited. Please provide the data in one of our recommended file formats. More detailed instructions are available at http://olabout.wiley.com/WileyCDA/Section/id-828014.html.
Graphical abstracts
The journal publishes graphical abstracts in its online table of contents and content alert emails. This is an opportunity to create a concise text summary (or not more than 60 words) together with a clear visual representation of your article's main message to attract potential readers (remember: 'a picture is worth a thousand words'). Ideally, graphical abstract files should be colour images containing one or two graphical elements and should be visually attractive and contain minimal text. The main objective of a graphical abstract file is to capture the main message or topic of your paper, at a glance, drawing the reader towards the article. For examples, see a sample issue at https://febs.onlinelibrary.wiley.com/toc/22115463/2018/8/1
Cover illustrations
Authors with a colour figure appearing in an accepted paper that they believe would make a good image for the Journal cover are invited to submit a copy of the figure, 21 cm (width) by 16 cm (height), in colour, without any labels or scale bars. Please supply an electronic copy of the figure, with a short legend (max. 15 words), following instructions in the Preparation of electronic artwork for publication section.
Nomenclature, abbreviations, units and symbols
Abbreviations and nomenclature should follow internationally agreed recommendations, e.g. those of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (see www.chem.qmw.ac.uk/iubmb/nomenclature). However:
Authors may use commonly used abbreviations/acronyms but these must be defined in the text at first citation and included in the Abbreviations list.
SI units and quantities should be used (see http://www.bipm.fr/enus/3_SI/si.html) but Å, cal, p.p.m. can be used where appropriate.
It is often convenient, especially in figures and table headings, to give a multiple of the quantity set or measured by multiplying it by a stated factor. The units in which it is expressed should not be multiplied by a number but may be indicated by prefixes such as: M, k, m, µ, n or p.
A negative index style is used for units.
Square brackets are commonly used to indicate concentrations.
Math formulae
Present simple formulae in the line of normal text where possible and use the solidus (/) instead of a horizontal line for small fractional terms, e.g., X/Y. Variables are normally presented in italics. Powers of e are often more conveniently denoted by “exp”. Number consecutively any equations that have to be displayed separately from the text (if referred to explicitly in the text).
……
